[ad_1]
A team of British scientists developed eye drops that could represent a revolution in the treatment of age-related macular degeneration (AMD), the leading cause of blindness in the world.
(AMD) is currently undergoing eye drug injections, which should be administered by specialists, and it is estimated that by 2020 there will be about 200 million people suffering from degeneration degenerative macular related to aging in the world.
However, British scientists at the University of "Birmingham" British alternative treatment in the form of deposit
The new study has shown that developed eye drops can be used to reduce the symptoms of degeneration of age-related macrophages in rabbits and pigs. (19659004) "In several years, our team has focused on the challenge of communication ," said Dr. Felicity de Kogan, a biochemist in 19659002. on the posterior from the eye, adding that from the beginning, we realized that delivery of drugs from (19659002) and health care providers by reducing possible complications which [19659004] can be caused by injections. "
Eye drops mean that patients can manage their own treatment, The developed peptide droplet that works on breakthrough cells is made to connect the drug to the posterior retina [19659004] of the eye, and clinical trials should begin on humans as early as 2019.
Robert Scott, professor at the University of Birmingham, said: "The permeable peptides of cells will lead the next generation treatments for
var js, fjs = d.getElementsByTagName (s) [0];
if (d.getElementById (id)) returns;
js = d.createElement (s); js.id = id;
js.src = "http://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.3&appId=1377051052530512";
fjs.parentNode.insertBefore (js, fjs);
} (document, 'script', 'facebook-jssdk'));
[ad_2]
Source link
